» Articles » PMID: 17713418

Metabolism Modulators in Sepsis: Propranolol

Overview
Journal Crit Care Med
Date 2007 Sep 22
PMID 17713418
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Sepsis is accompanied by an enormous increase in catecholamine expression, leading to metabolism of lipids and glucose, changes in cardiovascular output, immunomodulatory effects, and changes in protein metabolism, all of which push the body into a catabolic state. Deleterious beta-adrenoceptor controlled responses to stress and sepsis are well documented; therefore, it would seem appropriate to use propranolol under such circumstances. There are arguments both for and against the use of beta-adrenoceptor blockade during episodes of stress and infection. The definition of sepsis itself is a clinical one in most cases. There are guidelines concerning the diagnosis of sepsis (systemic inflammatory response syndrome [SIRS] in the presence of significant infection). However, when the cause of SIRS is not infection, for example, in burn patients, is it not possible, and indeed preferable, to tackle the stress response in a more aggressive fashion? The effects of SIRS on the body are myriad and have been defined and illustrated in many fine reviews. The effects of sepsis on the body, as well, have been discussed in the world literature and are beyond the scope of this article. In this article we attempt to demonstrate the effects of sepsis (SIRS plus infection) on whole body metabolism, outline the mediators of these changes, and then show the ability of propranolol to attenuate the changes seen.

Citing Articles

The value of D-dimer-albumin ratio as a prognostic biomarker in critically ill patients with sepsis: A retrospective single-center study.

Zhang J, Song C, Hu Z Heliyon. 2024; 10(20):e39057.

PMID: 39640745 PMC: 11620166. DOI: 10.1016/j.heliyon.2024.e39057.


Elevated serum albumin-to-creatinine ratio as a protective factor on clinical outcomes among critically ill patients with sepsis: a retrospective study.

Hu Z, Song C, Zhang J Front Med (Lausanne). 2024; 11:1436533.

PMID: 39364026 PMC: 11446770. DOI: 10.3389/fmed.2024.1436533.


Clinical predictive value of the CRP-albumin-lymphocyte index for prognosis of critically ill patients with sepsis in intensive care unit: a retrospective single-center observational study.

Zhang J, Zhao Q, Liu S, Yuan N, Hu Z Front Public Health. 2024; 12:1395134.

PMID: 38841671 PMC: 11150768. DOI: 10.3389/fpubh.2024.1395134.


Sepsis as a Pan-Endocrine Illness-Endocrine Disorders in Septic Patients.

Wasyluk W, Wasyluk M, Zwolak A J Clin Med. 2021; 10(10).

PMID: 34066289 PMC: 8152097. DOI: 10.3390/jcm10102075.


Premorbid β1-selective (but not non-selective) β-blocker exposure reduces intensive care unit mortality among septic patients.

Kuo M, Chou R, Lu Y, Guo J, Tsai Y, Wu C J Intensive Care. 2021; 9(1):40.

PMID: 33985572 PMC: 8116825. DOI: 10.1186/s40560-021-00553-9.